BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8697967)

  • 1. [p53 gene point mutation in human colorectal carcinoma].
    Xu W; Yang D; Wan Y
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):328-31. PubMed ID: 8697967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
    Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Gene mutations in sporadic colorectal carcinoma in Guangxi region.
    Gao F; Li C; Li W; Chen L; Tang Z; Tang W
    Cancer Invest; 2006 Nov; 24(7):689-95. PubMed ID: 17118779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.
    Kastrinakis WV; Ramchurren N; Rieger KM; Hess DT; Loda M; Steele G; Summerhayes IC
    Oncogene; 1995 Aug; 11(4):647-52. PubMed ID: 7651727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity and p53 gene mutation in familial polyposis coli.
    Ikeguchi M; Makino M; Kaibara N
    Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The significance of p53 gene mutations and expressions in human colorectal tumors].
    Qian H; Yu B; Zhou X
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):332-5. PubMed ID: 8697968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
    Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
    Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrations of the p53 tumor suppressor gene in human epithelial ovarian carcinoma.
    Kim JW; Cho YH; Kwon DJ; Kim TE; Park TC; Lee JM; Namkoong SE
    Gynecol Oncol; 1995 May; 57(2):199-204. PubMed ID: 7729734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the tumor suppressor gene p53 in human liver cancer induced by alpha-particles.
    Andersson M; Jönsson M; Nielsen LL; Vyberg M; Visfeldt J; Storm HH; Wallin H
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):765-70. PubMed ID: 8672994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [p53 gene mutation in cancer of the colon and rectum].
    Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
    Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping of p53 codon 175 in colorectal cancer.
    Krajewska WM; Stawińska M; Bryś M; Młynarski W; Witas HW; Okruszek A; Kiliańska ZM
    Med Sci Monit; 2003 May; 9(5):BR188-91. PubMed ID: 12761448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene point mutations in relation to p53 nuclear protein accumulation in colorectal cancers.
    Costa A; Marasca R; Valentinis B; Savarino M; Faranda A; Silvestrini R; Torelli G
    J Pathol; 1995 May; 176(1):45-53. PubMed ID: 7616356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance in molecular detection of p53 mutation in serum of patients with colorectal carcinoma.
    Ito T; Kaneko K; Makino R; Konishi K; Kurahashi T; Ito H; Katagiri A; Kushima M; Kusano M; Mitamura K; Imawari M
    Oncol Rep; 2003; 10(6):1937-42. PubMed ID: 14534722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer.
    Guldberg P; Nedergaard T; Nielsen HJ; Olsen AC; Ahrenkiel V; Zeuthen J
    Hum Mutat; 1997; 9(4):348-55. PubMed ID: 9101296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer.
    Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T
    J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tumour suppressor p53 gene sequence mutations in pleomorphic adenoma of salivary gland].
    Wang J; Dong F; Yong P
    Zhonghua Yi Xue Za Zhi; 1999 Oct; 79(10):777-9. PubMed ID: 11715527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological study of p53 tumor suppressor gene mutations in patients from Luxembourg and the German Saar region with an advanced colorectal cancer using PCR-SSCP analysis.
    Pauly M; Schmitz M; Kayser I; Lagoda P; Türeci O; Kerschen A; Weber J; Seitz G; Hentges F; Dicato M
    Biomed Pharmacother; 1998; 52(5):220-8. PubMed ID: 9755819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.